ICRF-1887 perits longer treatment with doxorubicin in women with breast cancer - Speyer, JL; Green, MD; Zleniuch-Jacquotte, A; Wernz, JC; Rey, M; Sanger, J (J Clin Oncol, 1992)
et al.